Pacific Oak Strategic Opportunity REIT, Inc.
PCOK
$2.70
$0.2098.39%
| Weiss Ratings | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -34.85 | |||
| Price History | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 10.38% | |||
| 90-Day Total Return | -3.57% | |||
| Year to Date Total Return | 10.38% | |||
| 1-Year Total Return | -40.00% | |||
| 2-Year Total Return | 10,700.00% | |||
| 3-Year Total Return | -66.12% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -36.47% | |||
| 52-Week Low % Change | 10.38% | |||
| Price | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.25 | |||
| 52-Week Low Price | $2.45 | |||
| 52-Week Low Price (Date) | Dec 31, 2024 | |||
| 52-Week High Price (Date) | May 02, 2024 | |||
| Valuation | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 277.97M | |||
| Enterprise Value | 1.19B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.66 | |||
| Earnings Per Share Growth | 26.34% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.52 | |||
| Price/Book (Q) | 2.91 | |||
| Enterprise Value/Revenue (TTM) | 15.09 | |||
| Price | $2.70 | |||
| Enterprise Value/EBITDA (TTM) | -54.19 | |||
| Enterprise Value/EBIT | -17.41 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 102.97M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 424 208 8100 | |||
| Address | 11766 Wilshire Boulevard Los Angeles, CA 90025 | |||
| Website | pacificoakcapitalmarkets.com/offering/reit | |||
| Country | United States | |||
| Year Founded | 2008 | |||
| Profitability | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -86.69% | |||
| Profit Margin | -216.91% | |||
| Management Effectiveness | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -3.40% | |||
| Return on Equity | -- | |||
| Income Statement | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 124.01M | |||
| Total Revenue (TTM) | 78.96M | |||
| Revenue Per Share | $0.77 | |||
| Gross Profit (TTM) | -17.24M | |||
| EBITDA (TTM) | -21.99M | |||
| EBIT (TTM) | -68.45M | |||
| Net Income (TTM) | -171.28M | |||
| Net Income Avl. to Common (TTM) | -171.28M | |||
| Total Revenue Growth (Q YOY) | -11.25% | |||
| Earnings Growth (Q YOY) | 26.92% | |||
| EPS Diluted (TTM) | -1.66 | |||
| EPS Diluted Growth (Q YOY) | 26.98% | |||
| Balance Sheet | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 19.47M | |||
| Cash Per Share (Q) | $0.19 | |||
| Total Current Assets (Q) | 88.73M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 92.23M | |||
| Current Ratio (Q) | 0.789 | |||
| Book Value Per Share (Q) | $0.93 | |||
| Total Assets (Q) | 1.11B | |||
| Total Current Liabilities (Q) | 112.48M | |||
| Total Debt (Q) | 936.41M | |||
| Total Liabilities (Q) | 1.02B | |||
| Total Common Equity (Q) | 95.36M | |||
| Cash Flow | PCOK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 80.31M | |||
| Cash from Financing (TTM) | -134.57M | |||
| Net Change in Cash (TTM) | -85.23M | |||
| Levered Free Cash Flow (TTM) | -20.95M | |||
| Cash from Operations (TTM) | -34.56M | |||
